Beruflich Dokumente
Kultur Dokumente
Lvia Jnoskuti
Definition
Kidney diseases that involve structures in the
kidney outside the glomerulus
Tubules and/ or the interstitium
Tubules are responsible for concentrating the
urine(osmolality, sodium and water reabsorption)
Reduction of tubular or interstitial function both
result in: impaired resorptive capacity
Isosthenuria:urin osm. the same as blood
< 350 mosmol/kg
Characteristics of tubulointerstitial
and glomerural diseases
Tubular
Glomerular
Urine osmolality
Low <350mos/kg
High/norm
Urine sodium
>40mM/L
<40
U. sediment
Muddy brown
Red cell casts
casts(ATN)
Eosinophils(AAIN)
hematuria
rare
common
proteinuria
rare
common
Causes
Concom.illness
Drugs common
Autoimmun or
congen.
Therapy
Supportive/dialysis Steroids,immunmo
dulators
Pathophysiology
Lethal, sublethal injuri to renal cells lead to
expression of new local antigens, inflammatory
cell infiltration and activation of proinflammatory
cells and cytokines
Acute- renal tubular dysfunction with or without
renal failure ( If the tubular basement mebrane is
preserved- reversibile)
Chronic- interstitial scarring fibrosis, tubule
atrophy- resulting progressive renal failure
Clinical presentation
Acute
Abruptly, within days of exposure to the
offending agent
Uremic symptoms: oliguria
ATN
U Na mM/L
<20
>40
FE Na
<1%
>1%
U osm mM/kg
>500
<350
BUN/creat
>20:1
10-15:1
U sediment
Hyalin casts
Brown casts
Contrast nephropathy
Progressive rise in Se creat 24-48 h after
radiocontrast is given
Risk factors: older age, DM, HF,MM. preexisting
chr.kidney disease,liver failure
Th:supportive
Prevention:avoiding contrast(when possible),
low dose low osmolality contrast agent use,
isotonic fluid infusion 1ml/kg/h 6-12h before and
after the contrast,600mgacetylcystein pos before
the day and the day of contrast
Livedo reticularis
Hollenhorst plaques
( bright plaques in the retinal arterioles
Myeloma-related RI.
Cause:overproduction of monoclonal Ig light
chain( Bence Jones protein) by pathologic
B cell clonal population
Sy: MM and uremic
Dg. 24h urin protein ELFO
Th: MM therapy.
Toxin mediated RI
Cause : drugs, but not occure after the first
dose (NSAID,aminoglycoside,
amphotericinB, cisplatin, cephalopsorins,
cyclosporin)
Sy: uremic, following longer term th.(daysweeks) No fever, no rash
Th:dependent on drug.
Prevention: ensure widest spacing of dose,
estimation of drug plasma levels
Papillary necrosis
Cause: NSAID, acetaminophen ingestion in
patients with DM, liver cirrhosis, sickle cell
disease
Sy: fever,flank pain( appears like UTI)
Dg: no WBC or elevated nitrits in urin.
Elevated serum WBC
Confirm with spiral CT.
Th: stop offending drug.
Prevention: avoid excessive use of NSAID
Clinical presentation
2.Chronic
Epidemiology
10-15% of all kidney diseases
Analgesic nephropathy is 5-6 times more
common in women
All toxic nephropathies are observed more
frequently with adavancing age
(cummulative effects)
Clinical presentation
Chronic
Insidious nature
Often diagnosed incidentally on routine
laboratory screening, or evaluation of
hypertension
Modest proteinuria, sterile pyuria, anemia, renal
insuff ( NSAID)
Polyuria concentration defect (lithium)
Modest proteinuria, hyperK renal tub. acidosis in
chr. obstruction
Arterioscler. kidney: modest proteinuria, kreatinin
and BUN elevation, hypertension
Laboratory
BUN , kreatinin- renal failure
Low bicarbonate < 24 mEq L- acidosisph<7,35
With hypoK proximal tub. disorder
With hyperK- distal tub disoreder
Urinalysis: hematuria and pyuria with-or without
bacteria, casts, eosinophils, crystals
Urine protein usually less >1-2 gr/24h
Protein ELFO- low mol. weight (beta-2
microglob,alfa-1 microglob., light chains)
Imaging
US/ and flat plate kidney- hydronephrosis, renal
calculi
Normal kidney size favours acute
Small kidneys with increased echogenicity- chr .
disease
Iv pyelography usually not indicated- contrast
damage
CT(high resolutional) scan show
microcalcifications in renal papillary tipsdiagnosing analgesic nephropathy
Nephrosclerosis CT
Hydronephrosis US
Analgesic nephropathy CT
microcalcifications
Management of chr.
Tubulointerstitial disease
Depends on the etiology- generally stop of the
offending drug and supportive measures-blood
pressure and anemia control
Analgesic- increased uroepitheal cc
Lead- chelation th. with EDTA
Atheroscler.- no specific th.-smoking cessation,
cholesterol diet and statins
Reflux nephropathy, urinary tract
obstruction:surgical treatment, antibiotics
Prognosis
Most patients with allergic inerstitial
nephritis recover upon cessation of the
offending agent
Cholesterol microembolic diseases have
some spontaneous improvement,
complete resolution is rare
Chr. Tubulointerstitial d. progresses to
ESRD.